Xcout IntelImpediMed
Operating as a medical software technology provider, ImpediMed Limited is responsible for the development, production, and global sales of bioimpedance spectroscopy (BIS) instruments and accompanying software solutions, serving markets in Australia, North America, and internationally. Its product portfolio features SOZO, a non-invasive BIS device used for evaluating lymphedema and tracking fluid levels in heart failure patients. Additionally, it offers the SFB7, a single-channel, tetrapolar BIS instrument for analyzing body composition in healthy individuals, and ImpediVET, another single-channel, tetrapolar BIS device specifically designed for veterinary applications to measure fluid status and tissue composition. ImpediMed primarily sells its technology to hospitals and clinics. This Australian-headquartered firm, based in Pinkenba, was established in 1999.
Subscribe to see ImpediMed’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ImpediMed at a glance
ImpediMed is a medical devices company headquartered in Carlsbad, United States. It is publicly listed (IPD) with a market capitalisation of $7.4M. Xcout tracks 12 named people at ImpediMed, including Erik Anderson (Managing Director & CEO).
ImpediMed leadership
- Erik AndersonManaging Director & CEO
- McGregor GrantExecutive Director & CFO
- Scott SavageChief Product Officer
- Scott LongSVP, US Sales, Key Accounts, and Renewals
- Ashley MuñozDirector, Human Resources
- Blake AhitowSenior Director, Customer Success & Strategic Accounts
6 more named people on record for ImpediMed, with roles, board committees and tenure — see the full roster →
ImpediMed competitors
A few of ImpediMed's closest competitors — see the full list of competitors and alternatives →
SunTech Medical designs and manufactures clinical-grade blood pressure monitoring products and OEM non-invasive blood pressure (NIBP) solutions. The company serves human healthcare providers, medical equipment manufacturers, and veterinary professionals with devices such as ambulatory blood pressure monitors, stress test monitors, and specialized animal monitors.
Zomedica Corp. develops and provides products and services for clinical veterinarians, including diagnostic technology, targeted pulsed electromagnetic field therapy, shock wave therapy systems, and hemostatic gel. The company aims to support veterinary practices in delivering patient care and improving clinical outcomes.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Biobeat is a medical technology company that develops FDA-cleared, cuffless ambulatory blood pressure monitoring solutions. Their technology is designed to empower clinicians in the diagnosis and management of hypertension.
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
BIOTRONIK SE & Co. KG designs, manufactures, and provides medical devices and technologies for cardiac rhythm management, vascular intervention, and neuromodulation. The company's product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) systems, implantable cardiac monitors, and remote patient monitoring solutions. BIOTRONIK serves healthcare professionals, hospitals, and patients by offering solutions for the diagnosis, treatment, and management of heart diseases and chronic pain.
Get ImpediMed's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ImpediMed in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access